KeyBank National Association’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-33,614
| Closed | -$570K | – | 1029 |
|
|
2018
Q3 | $570K | Sell |
33,614
-5,419
| -14% | -$91.9K | ﹤0.01% | 737 |
|
|
2018
Q2 | $554K | Buy |
39,033
+13,921
| +55% | +$198K | ﹤0.01% | 714 |
|
|
2018
Q1 | $477K | Sell |
25,112
-12,697
| -34% | -$241K | ﹤0.01% | 754 |
|
|
2017
Q4 | $620K | Sell |
37,809
-3,718
| -9% | -$61K | ﹤0.01% | 689 |
|
|
2017
Q3 | $623K | Sell |
41,527
-43,630
| -51% | -$655K | ﹤0.01% | 715 |
|
|
2017
Q2 | $749K | Sell |
85,157
-50,090
| -37% | -$441K | ﹤0.01% | 686 |
|
|
2017
Q1 | $703K | Hold |
135,247
| – | – | ﹤0.01% | 712 |
|
|
2016
Q4 | $413K | Buy |
135,247
+40,854
| +43% | +$125K | ﹤0.01% | 868 |
|
|
2016
Q3 | $437K | Buy |
94,393
+13,148
| +16% | +$60.9K | ﹤0.01% | 865 |
|
|
2016
Q2 | $470K | Buy |
81,245
+9,215
| +13% | +$53.3K | ﹤0.01% | 795 |
|
|
2016
Q1 | $436K | Buy |
72,030
+5,465
| +8% | +$33.1K | ﹤0.01% | 820 |
|
|
2015
Q4 | $608K | Buy |
66,565
+3,881
| +6% | +$35.4K | ﹤0.01% | 716 |
|
|
2015
Q3 | $354K | Buy |
62,684
+24,598
| +65% | +$139K | ﹤0.01% | 902 |
|
|
2015
Q2 | $422K | Buy |
38,086
+12,394
| +48% | +$137K | ﹤0.01% | 888 |
|
|
2015
Q1 | $403K | Sell |
25,692
-1,826
| -7% | -$28.6K | ﹤0.01% | 920 |
|
|
2014
Q4 | $419K | Buy |
27,518
+2,260
| +9% | +$34.4K | ﹤0.01% | 913 |
|
|
2014
Q3 | $272K | Sell |
25,258
-4,443
| -15% | -$47.8K | ﹤0.01% | 1078 |
|
|
2014
Q2 | $454K | Buy |
29,701
+1,436
| +5% | +$22K | ﹤0.01% | 934 |
|
|
2014
Q1 | $511K | Sell |
28,265
-7,169
| -20% | -$130K | ﹤0.01% | 893 |
|
|
2013
Q4 | $492K | Buy |
35,434
+4,168
| +13% | +$57.9K | ﹤0.01% | 915 |
|
|
2013
Q3 | $328K | Sell |
31,266
-2,835
| -8% | -$29.7K | ﹤0.01% | 1015 |
|
|
2013
Q2 | $266K | Buy |
+34,101
| New | +$266K | ﹤0.01% | 1162 |
|